[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100626412":3},{"organization":4,"outcomesModule":7,"designInfo":33,"detailedDescription":44,"studyPopulation":32,"armGroups":45,"interventions":56,"overallOfficials":62,"centralContacts":67,"locations":72,"responsibleParty":87,"collaborators":89,"id":91,"slug":92,"hasResults":93,"nctId":94,"briefTitle":95,"officialTitle":96,"acronym":32,"eligibilityCriteria":97,"healthyVolunteers":93,"sex":98,"minAge":99,"maxAge":100,"enrollmentInfo":101,"targetDuration":32,"studyType":104,"phases":105,"briefSummary":107,"conditions":108,"keywords":32,"overallStatus":75,"whyStopped":32,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":119},{"fullName":5,"class":6},"National University Hospital, Singapore","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":19,"otherOutcomes":32},[9,13,15,17],{"measure":10,"description":11,"timeFrame":12},"Tinnitus Handicap Inventory (THI)","THI consists of a 25 items which evaluate the subjective burden of tinnitus under a three-response system: yes (score = 4), sometimes (score = 2), or no (score = 0). THI scores of 18-36 are considered as mild tinnitus, 38-56 are considered moderate, and 58-76 are considered severe, while 78-100 are considered catastrophic.","Week 0",{"measure":10,"description":11,"timeFrame":14},"Week 3",{"measure":10,"description":11,"timeFrame":16},"Week 6",{"measure":10,"description":11,"timeFrame":18},"Week 7",[20,23,24,25,26,29,30,31],{"measure":21,"description":22,"timeFrame":12},"Tinnitus Functional Index (TFI)","Tinnitus Functional Index (TFI) is a 25-item questionnaire with a 10-point Likert scale covering eight underlying dimensions: (a) intrusiveness of tinnitus; (b) sense of control; (c) cognitive interference; (d) sleep disturbance; (e) auditory difficulties; (f) interference with relaxation; (g) quality of life; and (h) emotional distress.",{"measure":21,"description":22,"timeFrame":14},{"measure":21,"description":22,"timeFrame":16},{"measure":21,"description":22,"timeFrame":18},{"measure":27,"description":28,"timeFrame":12},"Tinnitus-Visual Analogue Scale (T-VAS)","T-VAS is a clinical scale of the severity of tinnitus in loudness (sound), distress, and Quality of Life (QoL). The minimum value is 0 and the maximum value is 100. A higher score indicates a worse outcome, as it reflects greater perceived tinnitus loudness or severity. A score of 0 represents no tinnitus, while a score of 100 represents the worst imaginable tinnitus.",{"measure":27,"description":28,"timeFrame":14},{"measure":27,"description":28,"timeFrame":16},{"measure":27,"description":28,"timeFrame":18},null,{"allocation":34,"interventionModel":35,"interventionModelDescription":36,"primaryPurpose":37,"observationalModel":32,"timePerspective":32,"maskingInfo":38},"RANDOMIZED","CROSSOVER","The study design is an open-label, prospective, sham-controlled crossover trial of neuronavigated TMS vs sham TMS.","TREATMENT",{"masking":39,"maskingDescription":40,"whoMasked":41},"DOUBLE","Assessor and participant will be blinded to the sequence of nTMS assigned to the subject.",[42,43],"PARTICIPANT","OUTCOMES_ASSESSOR","This study aims to investigate the beneficial effects of neuronavigated TMS (nTMS) in alleviating tinnitus symptoms and to establish safety and tolerability of nTMS in patients with tinnitus.\n\n50 eligible subjects will be recruited and be randomized to receive 10 sessions of daily verum nTMS followed by 10 sessions of daily sham nTMS (verum-sham), or sham nTMS followed by verum nTMS (sham-verum). There will be a 2-week break between the two types of nTMS.\n\nMRI will be conducted before the 1st session of nTMS for the TMS navigation system.\n\nOutcome measures include Tinnitus Handicap Inventory (THI), Tinnitus Functional Index (TFI), and Tinnitus-Visual Analogue Scale (T-VAS). All assessment will be evaluated 4 times- before the 1st nTMS session, after the 10th nTMS session, before the 11th nTMS and after the 20th nTMS session.",[46,52],{"label":47,"type":48,"description":49,"interventionNames":50},"real-sham","EXPERIMENTAL","Subjects will receive 10 sessions of real nTMS, 5 times a week for 2 weeks, followed by 10 sessions of sham nTMS, 5 times a week for 2 weeks. There will be a 2-week break between the 2 types of nTMS.",[51],"Device: navigated rTMS",{"label":53,"type":48,"description":54,"interventionNames":55},"sham-real","Subjects will receive 10 sessions of sham nTMS, 5 times a week for 2 weeks, followed by 10 sessions of real nTMS, 5 times a week for 2 weeks. There will be a 2-week break between the 2 types of nTMS.",[51],[57],{"type":58,"name":59,"description":60,"armGroupLabels":61,"otherNames":32},"DEVICE","navigated rTMS","Each session of rTMS (real or sham) consists of 1200 stimulations\u002Fday, conducted at once a day for five consecutive days (from Monday to Friday).\n\nFor sham stimulation, the TMS coil will still centre on the same scalp position, but it was tilted to 90° so that scalp contact and discharging noise were similar, but the magnetic field did not reach cortical neurons at a biologically active level.\n\nThe localization of the rTMS stimulation site (left Temporal Cortex) will be directed by a neuronavigation system imported with subject's MRI scan imaging to ensure the accuracy of rTMS stimulation area.",[47,53],[63],{"name":64,"affiliation":65,"role":66},"Nicodemus Oey, MBBS, PhD","NUH","PRINCIPAL_INVESTIGATOR",[68],{"name":64,"role":69,"phone":70,"phoneExt":32,"email":71},"CONTACT","8798 5734","nicodemus_edrick_oey@nuhs.edu.sg",[73],{"facility":74,"status":75,"city":76,"state":32,"zip":32,"country":76,"countryCode":77,"cosmosGeoPoint":78,"geoPoint":83,"contacts":84},"Alexandra Hospital","RECRUITING","Singapore","SG",{"type":79,"coordinates":80},"Point",[81,82],103.85007,1.28967,{"lat":82,"lon":81},[85],{"name":86,"role":69,"phone":70,"phoneExt":32,"email":71},"Nicodemus Edrick Oey, MBBS, PhD",{"type":88,"investigatorFullName":32,"investigatorTitle":32,"investigatorAffiliation":32,"oldNameTitle":32,"oldOrganization":32},"SPONSOR",[90],{"name":74,"class":6},"100626412","navigated-repetitive-tms-for-chronic-tinnitus-100626412",false,"NCT07435298","Navigated Repetitive TMS for Chronic Tinnitus","Neuronavigated Transcranial Magnetic Stimulation As An Adjunctive Treatment For Chronic Tinnitus","Inclusion Criteria:\n\n1. Age 21-80 years old;\n2. Subjective tinnitus severity as per Tinnitus-Visual Analogue Scale of 1\u002F10 and above (in any domain: sound, distress, Quality of Life)\n\nExclusion Criteria:\n\n1. Pregnancy;\n2. Any metal implants inside the body that are contraindications of MRI scan;\n3. Cardiac pacemakers;\n4. Epilepsy with recurrent seizures;\n5. Cognitively impaired patients will be excluded;\n6. Claustrophobia;\n7. Uncontrolled medical conditions including hypertension, diabetes mellitus and unstable angina;\n8. Major depression and a history of psychotic disorders;\n9. Terminal diagnosis with life expectancy \\\u003C=1 year.","ALL","21 Years","80 Years",{"count":102,"type":103},50,"ESTIMATED","INTERVENTIONAL",[106],"NA","This study is testing whether a special type of brain stimulation called neuronavigated TMS can help reduce tinnitus (ringing in the ears). 50 people with tinnitus will each receive 20 treatment sessions - 10 real treatments and 10 sham treatments in random order, with a 2-week break between them. Before starting, participants get an MRI brain scan to guide where the stimulation device is placed. Questionnaires of measuring tinnitus severity will be asked four times throughout the study to determine to check the effect of TMS on treating tinnitus.",[109],"Tinnitus","2026-08-20",{"date":112,"type":113},"2026-08-24","ACTUAL",{"date":115,"type":113},"2025-11-01",{"date":117,"type":103},"2027-10-30",{"name":5,"class":6},1]